Treatment of Cyclothymic Disorder: Commentary

^aDepartment of Psychiatry, Harvard Medical School and Psychopharmacology Program, McLean Division of Massachusetts General Hospital, Boston, Mass., and

^bInternational Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, Mass., USA;

^cDepartment of Neuroscience, University of Palermo, Buenos Aires, Argentina;

^dLucio Bino Mood Disorders Center, Cagliari, Italy